期刊文献+

老年患者丙戊酸脑病4例分析 被引量:1

Analysis of 4 Cases of Elderly Valproate Encephalopathy
下载PDF
导出
摘要 目的:回顾分析老年患者丙戊酸脑病的临床及实验室检查特点,提高对丙戊酸脑病的认识及诊断水平。方法:收集我院神经内科2010年1月-2014年12月应用丙戊酸钠(VPA)后确诊为丙戊酸脑病患者4例,比较其临床表现及实验室检查的特点。结果:4例患者中男3例,女1例,平均年龄(70.3±9.8)岁;均为单用VPA;表现为意识障碍、认知功能下降;肝功能及丙戊酸钠血药浓度均在正常范围,血氨浓度升高;脑电图提示广泛漫波增多,以θ和δ波占优;4例患者停用VPA 2周后症状改善,血氨浓度下降。结论:丙戊酸脑病突出临床表现为意识障碍、认知功能下降,临床使用VPA时应予以高度重视。及时停药后症状可逐缓解,其愈后良好。 Objective: Retrospective analyzed the clinical and laboratory examination features of valproate encephalopathy in senile patients,to improve the comprehending and diagnostic level on valproate encephalopathy. Methods: Compared the clinical and laboratory characteristics of 4 patients of valproate encephalopathy after treating with valproic acid from neurology department of our hospital from January 2010 to December 2014. Results: The average age of 4 patients( 3 men and 1 woman) was( 70. 3 ± 9. 8) years,who were treated by valproic acid alone. The all cases showed consciousness disorder and cognitive impairment. Both liver function and valproate plasma concentration were within the normal range,but the plasma ammonia concentration was increasing. Furthermore,EEG indicated slow- waves increased widely,especially θ and δ waves. The 4 cases experienced a clinically significant improvement in symptoms in 2 weeks after stopping use of valproic acid,whose plasma ammonia concentration came down. Conclusion: The prominent clinical manifestations of valproate encephalopathy were consciousness disorder and cognitive decline. So we should pay high attention to the clinical application of valproic acid. Fortunately,those related symptoms would get alleviated gradually after cessation of valproate timely,and the prognosis of it was favorable.
作者 叶维 杜远敏
出处 《药物流行病学杂志》 CAS 2016年第3期170-172,共3页 Chinese Journal of Pharmacoepidemiology
关键词 丙戊酸钠 丙戊酸脑病 药品不良反应 Valproic acid Valproic acid induced encephalopathy Adverse drug reaction
  • 相关文献

参考文献16

  • 1Segura-Bruna N, Rodriguez A, Puente V. Valproate in-duced hyperammonemic eneephalopathy [ J ]. Acta Neurol Scand, 2006, 114(1):1-7.
  • 2Wu ZM. One report of Valproie acid sodium encephalopathy [J]. Chin J Pract Inter Med, 2010, 30:568.
  • 3Perucca E. Pharmacological and therapeutic properties of valproate: A Summary After 35 Years of Clinical Experience [J]. Cns Drugs, 2002, 16(10) :695-714.
  • 4Fassi G, Igoa A, Liste OA. Valproate-induced hyperam- monemic encephalopathy: review of cases in the psychiatric setting[J]. Vertex, 2008, 19:371-377.
  • 5李国良,肖波.丙戊酸钠脑病[J].国外医学(神经病学.神经外科学分册),2004,31(3):266-269. 被引量:9
  • 6Wadzinski J, Franks R, Roane D. Valproate-associated Hy- peramonemic Encephalopathy[ J ]. Board Fam Med, 2007, 20(7) :499-502.
  • 7Verrotti A, Trotta D, Morgese G, et al. Valproate-induced hyperammonemic encephalopathy [ J ]. Metabolic Brain Dis- ease, 2002, 17(4) :367-373.
  • 8Tsai MF, Chen CY. Valproate-induced hyperammonemic en- cephalopathy treated by hemodialysis[ J]. Ran Fail, 2008, 30 : 822-824.
  • 9Rousseau MC, Montana M, Villano P, etc. Valproic acid- induced encephalopathy in very long course treated patients [J]. Bain Inj, 2009, 23:981-984.
  • 10Chopra A, Kolla BP, Mansukhani MP, et al. Valproate in- duced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management [ J ]. Gen Hosp Psychiatry, 2012, 34:290-298.

二级参考文献19

  • 1O' Neill M, Dubrey RW, Grocott - Mason RM. Valproate encephalopathy and hyperammonaemia. Postgrad Med J, 2002, 78: 316-317.
  • 2Hamer HM, Knake S, Schomburg U, et al. Valproate - induced hyperammonemic encephalopathy in the presence of topiramate.Neurology, 2000, 54(1): 230-232.
  • 3Solomon GE. Valproate - induced hyperammonemic encephalopathy in the presence of topiramate. Neurology, 2000, 55(4) : 606.
  • 4Gobel R, Gortzen A, Bmunig P. Encephalopathies caused by valproate.Fortschr Neurol Psychiatr, 1999, 67(1) : 7 - 11.
  • 5Vossler DG, Wilensky AJ, Cawthon DF, et al. Serum and CSF glutamine levels in valproate - Mated hyperammonemic encephalopathy. Epilepsia,21302, 43(2) : 154 - 159.
  • 6Sobaniec - Lotowska ME. Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.Int J Exp Pathol, 2003, 84(3) : 115 - 125.
  • 7Ziyeh S, Thiel T, Sprecr J, et al. Valproate - induced encephalopathy:assessment with MR imaging and 1H - MR spectroscopy. Epilepsia,2002, 43(9): 1101 - 1105.
  • 8Schwarz S, Georgiadis D, Schwab S, et al. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy. J Neurol Neurosurg Psychiatry,2002, 73 : 90 - 91.
  • 9Fraser CM, Sills GJ, Forrest G, et al. Effects of antiepileptic drugs on glutamine synthetase activity in mouse brain. Br J Pharmacol, 1999,126: 1634- 1638.
  • 10Sobaniec- Lotowska ME. Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate, lnt J Exp Pathol, 2001, 82(6) : 337 - 348.

共引文献8

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部